Narayana Hrudayalaya (NH) M&A Announcement summary
Event summary combining transcript, slides, and related documents.
M&A Announcement summary
3 Feb, 2026Deal rationale and strategic fit
Entry into the mature U.K. healthcare market, leveraging experience from international operations and targeting a stable, developed sector with long-term growth potential.
Diversifies international revenues and capitalizes on the U.K.’s shift toward day care procedures and private pay models.
Practice Plus Group Hospitals was chosen for its optimal size, strong management team, and potential for operational improvement, with stable NHS relationships.
The acquisition aligns with a strategy to replicate operational efficiencies achieved in the Cayman Islands on a larger scale.
The U.K. private healthcare sector is underpenetrated, with private spend at 16-17% of total health expenditure, offering significant headroom for growth.
Financial terms and conditions
100% of the target acquired for approximately GBP 183 million, representing a 9.2x FY25E EV/EBITDA multiple.
GBP 150 million of acquisition debt at SONIA +200 bps, with GBP 40 million equity funded from the Cayman balance sheet; no India balance sheet cash used.
Acquisition of only the hospitals division, on a debt-free basis, with the seller repaying existing term loans.
All-in cost includes a 4-5% deal cost for diligence, stamp duty, and legal fees.
Post-IFRS FY25 EBITDA for the acquired business is GBP 29 million.
Synergies and expected cost savings
Plan to implement proprietary technology (Athma platform) and new clinical offerings to streamline operations, reduce administrative overhead, and improve throughput.
Operational efficiency and cost structure improvements are expected to drive margin expansion and faster cash conversion.
Asset-light, day care-focused model supports lower volatility and scalable growth.
No immediate need for additional doctors or infrastructure; growth to be driven by technology and process enhancements.
Latest events from Narayana Hrudayalaya
- Q3 FY26 delivered 61.2% YoY revenue growth and expansion, offset by one-time costs.NH
Q3 25/2617 Feb 2026 - Q1 FY25 saw record revenue, margin expansion, and new insurance and hospital launches.NH
Q1 24/2517 Feb 2026 - Q2 FY25 delivered revenue growth, margin gains, digital progress, and expansion plans.NH
Q2 24/2517 Feb 2026 - Q3 FY25 saw strong growth, margin recovery, digital progress, and major expansion investments.NH
Q3 24/2517 Feb 2026 - Strong FY25 revenue, EBITDA, expansion, digital growth, and a Rs. 4.50/share dividend.NH
Q4 24/2517 Feb 2026 - Q1 FY26 delivered strong revenue and margin growth, with expansion and digitalization ongoing.NH
Q1 25/2617 Feb 2026 - Q2 FY26 saw strong revenue and profit growth, margin expansion, and a major UK acquisition.NH
Q2 25/2617 Nov 2025